DV Biomed Co., Ltd.(TW:6539)
NT$36.200.00 (0.00%)
TW:6539
DV Biomed Co., Ltd. financials statements
NT$36.20
At close:0.00 (0.00%)
DV Biomed Co., Ltd. (6539) Ratios
DV Biomed Co., Ltd. Ratios
TW:6539's free cash flow for Q2 2026 was NT$16.82M. For the 2026 fiscal year, TW:6539's free cash flow was decreased by NT$-1.15M and operating cash flow was NT$17.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.55 | 4.01 | 1.57 | 2.09 | 2.20 |
| Quick Ratio | 2.83 | 3.49 | 1.32 | 1.81 | 1.93 |
| Cash Ratio | 0.83 | 1.54 | 0.58 | 0.95 | 1.14 |
| Solvency Ratio | 0.25 | 0.44 | 0.24 | 0.51 | 0.71 |
| Operating Cash Flow Ratio | 0.42 | 0.86 | 0.18 | 1.09 | 1.07 |
| Short-Term Operating Cash Flow Coverage | 3.71 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 319.28M | NT$ 313.49M | NT$ -149.92M | NT$ 97.63M | NT$ 393.63M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.17 | 0.21 | 0.23 | 0.12 |
| Debt-to-Equity Ratio | 0.09 | 0.25 | 0.37 | 0.41 | 0.19 |
| Debt-to-Capital Ratio | 0.08 | 0.20 | 0.27 | 0.29 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.33 | 1.45 | 1.73 | 1.79 | 1.58 |
| Debt Service Coverage Ratio | 2.83 | 73.33 | 1004.58 | 97.19 | 116.75 |
| Interest Coverage Ratio | 9.90 | 64.48 | 961.03 | 74.12 | 93.66 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.94 | 6.47 | 18.80 | 22.79 | 10.96 |
| Net Debt to EBITDA | -1.36 | -0.56 | 0.86 | 0.02 | -0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.35% | 74.01% | 49.68% | 55.67% | 55.95% |
| EBIT Margin | 1.87% | 22.23% | 10.48% | 21.38% | 23.43% |
| EBITDA Margin | 6.33% | 25.52% | 12.08% | 31.22% | 33.43% |
| Operating Profit Margin | 1.87% | 18.89% | 9.68% | 20.70% | 22.81% |
| Pretax Profit Margin | 1.27% | 21.93% | 10.47% | 19.56% | 21.66% |
| Net Profit Margin | 0.97% | 15.53% | 10.59% | 15.07% | 16.67% |
| Continuous Operations Profit Margin | 1.02% | 17.89% | 8.51% | 15.49% | 16.67% |
| Net Income Per EBT | 76.53% | 70.80% | 101.10% | 77.04% | 76.96% |
| EBT Per EBIT | 68.05% | 116.13% | 108.17% | 94.50% | 94.94% |
| Return on Assets (ROA) | 1.14% | 11.46% | 8.99% | 13.70% | 16.35% |
| Return on Equity (ROE) | 1.52% | 16.67% | 15.56% | 24.56% | 25.84% |
| Return on Capital Employed (ROCE) | 2.75% | 16.96% | 10.49% | 24.57% | 30.34% |
| Return on Invested Capital (ROIC) | 2.14% | 13.17% | 8.12% | 18.50% | 22.33% |
| Return on Tangible Assets | 1.15% | 11.52% | 9.03% | 13.72% | 16.39% |
| Earnings Yield | 0.54% | 8.19% | 6.61% | 10.21% | 10.49% |
| Efficiency Ratios | |||||
| Receivables Turnover | 20.04 | 16.79 | 7.10 | 7.27 | 5.96 |
| Payables Turnover | 6.28 | 4.54 | 27.65 | 7.50 | 6.98 |
| Inventory Turnover | 2.28 | 2.07 | 8.02 | 6.18 | 6.10 |
| Fixed Asset Turnover | 10.89 | 12.04 | 2.32 | 3.16 | 4.36 |
| Asset Turnover | 1.17 | 0.74 | 0.85 | 0.91 | 0.98 |
| Working Capital Turnover Ratio | 2.06 | 1.79 | 4.11 | 3.35 | 3.23 |
| Cash Conversion Cycle | 120.03 | 117.79 | 83.73 | 60.61 | 68.79 |
| Days of Sales Outstanding | 18.21 | 21.74 | 51.42 | 50.18 | 61.22 |
| Days of Inventory Outstanding | 159.98 | 176.49 | 45.51 | 59.08 | 59.88 |
| Days of Payables Outstanding | 58.16 | 80.43 | 13.20 | 48.64 | 52.31 |
| Operating Cycle | 178.19 | 198.22 | 96.93 | 109.25 | 121.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.39 | 5.77 | 3.37 | 25.24 | 25.05 |
| Free Cash Flow Per Share | 1.23 | 5.47 | 3.25 | 19.34 | 21.73 |
| Dividend Paid and CapEx Coverage Ratio | 0.89 | 1.37 | 0.23 | 1.22 | 1.32 |
| Capital Expenditure Coverage Ratio | 2.05 | 19.16 | 27.59 | 4.28 | 7.54 |
| Operating Cash Flow Coverage Ratio | 1.27 | 0.90 | 0.18 | 1.12 | 2.33 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.21 | 0.05 | 0.28 | 0.29 |
| Free Cash Flow Yield | 2.08% | 10.37% | 2.72% | 14.53% | 15.61% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 184.38 | 12.61 | 15.12 | 11.55 | 11.24 |
| Price-to-Sales (P/S) Ratio | 1.80 | 1.90 | 1.60 | 1.48 | 1.59 |
| Price-to-Book (P/B) Ratio | 2.81 | 2.04 | 2.35 | 2.41 | 2.46 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 48.13 | 9.64 | 36.73 | 6.88 | 6.41 |
| Price-to-Operating Cash Flow Ratio | 24.69 | 9.14 | 35.40 | 5.27 | 5.56 |
| Price-to-Earnings Growth (PEG) Ratio | -2.00 | -0.27 | -0.48 | -1.66 | 5.69 |
| Enterprise Value Multiple | 27.01 | 6.87 | 14.12 | 4.74 | 4.21 |
| Enterprise Value | 1.36B | 1.01B | 2.62B | 2.76B | 2.57B |
| EV to EBITDA | 27.01 | 6.87 | 14.12 | 4.74 | 4.21 |
| EV to Sales | 1.71 | 1.75 | 1.71 | 1.48 | 1.41 |
| EV to Free Cash Flow | 45.82 | 8.91 | 39.12 | 6.90 | 5.67 |
| EV to Operating Cash Flow | 23.50 | 8.45 | 37.70 | 5.29 | 4.92 |
| Tangible Book Value Per Share | 20.89 | 25.69 | 50.33 | 55.15 | 56.26 |
| Shareholders’ Equity Per Share | 20.98 | 25.89 | 50.74 | 55.31 | 56.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.18 | 0.19 | 0.21 | 0.23 |
| Revenue Per Share | 32.85 | 27.80 | 74.57 | 90.14 | 87.59 |
| Net Income Per Share | 0.32 | 4.32 | 7.90 | 13.59 | 14.60 |
| Tax Burden | 0.77 | 0.71 | 1.01 | 0.77 | 0.77 |
| Interest Burden | 0.68 | 0.99 | 1.00 | 0.91 | 0.92 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| SG&A to Revenue | 0.65 | 0.54 | 0.21 | 0.34 | 0.32 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 7.14 | 0.95 | 0.43 | 1.81 | 1.72 |
Currency in TWD
